Search Results - "Baker, Meghan A"

The impact of diabetes on tuberculosis treatment outcomes: a systematic review by Baker, Meghan A, Harries, Anthony D, Jeon, Christie Y, Hart, Jessica E, Kapur, Anil, Lönnroth, Knut, Ottmani, Salah-Eddine, Goonesekera, Sunali D, Murray, Megan B

“…Multiple studies of tuberculosis treatment have indicated that patients with diabetes mellitus may experience poor outcomes.We performed a systematic review…”
Get full text

Concise asymmetric synthesis of (−)-bilobalide by Baker, Meghan A., Demoret, Robert M., Ohtawa, Masaki, Shenvi, Ryan A.

“…The Ginkgo biloba metabolite bilobalide is widely ingested by humans but its effect on the mammalian central nervous system is not fully understood 1 – 4 …”
Get full text

Synthetic, Mechanistic, and Biological Interrogation of Ginkgo biloba Chemical Space En Route to (−)-Bilobalide by Demoret, Robert M, Baker, Meghan A, Ohtawa, Masaki, Chen, Shuming, Lam, Ching Ching, Khom, Sophia, Roberto, Marisa, Forli, Stefano, Houk, Kendall N, Shenvi, Ryan A

“…Here we interrogate the structurally dense (1.64 mcbits/Å3) GABAA receptor antagonist bilobalide, intermediates en route to its synthesis, and related…”
Get full text

Change the channel: CysLoop receptor antagonists from nature by Tong, Guanghu, Baker, Meghan A, Shenvi, Ryan A

“…Vertebrate and invertebrate ligand‐gated ion channels (LGICs) exhibit significant structural homology and often share ligands. As a result, ligands with…”
Get full text

Airborne Transmission of SARS-CoV-2: Theoretical Considerations and Available Evidence by Klompas, Michael, Baker, Meghan A, Rhee, Chanu

“…This Viewpoint discusses physical and epidemiological evidence supporting droplet vs aerosol transmission of severe acute respiratory syndrome coronavirus 2…”
Get full text

Airborne Transmission of SARS-CoV-2: Theoretical Considerations and Available Evidence by Klompas, Michael, Baker, Meghan A, Rhee, Chanu

Get full text

Kawasaki disease and 13-valent pneumococcal conjugate vaccination among young children: A self-controlled risk interval and cohort study with null results by Baker, Meghan A, Baer, Bethany, Kulldorff, Martin, Zichittella, Lauren, Reindel, Rebecca, DeLuccia, Sandra, Lipowicz, Hana, Freitas, Katherine, Jin, Robert, Yih, W Katherine

“…Kawasaki disease is an acute vasculitis that primarily affects children younger than 5 years of age. Its etiology is unknown. The United States Vaccine Safety…”
Get full text

Risk of Latent Tuberculosis Reactivation After Hematopoietic cell Transplantation by Cheng, Matthew P, Kusztos, Amanda E, Bold, Tyler D, Ho, Vincent T, Glotzbecker, Brett E, Hsieh, Candace, Baker, Meghan A, Baden, Lindsey R, Hammond, Sarah P, Marty, Francisco M

“…Abstract There were no cases of tuberculosis in a cohort of 2531 patients who underwent hematopoietic cell transplantation from 2010 to 2015 after 7323…”
Get full text

Changing patterns of asthma medication use related to US Food and Drug Administration long-acting β2 -agonist regulation from 2005-2011 by Butler, Melissa G., PharmD, MPH, PhD, Zhou, Esther H., MD, PhD, Zhang, Fang, PhD, Wu, Yu-te, PhD, Wu, Ann Chen, MD, MPH, Levenson, Mark S., PhD, Wu, Pingsheng, PhD, Seymour, Sally, MD, Toh, Sengwee, ScD, Iyer, Aarthi, MPH, Iyasu, Solomon, MD, MPH, Baker, Meghan A., MD, ScD

“…Background Safety concerns associated with long-acting β2 -agonists (LABAs) have led to many US Food and Drug Administration (FDA) regulatory activities for…”
Get full text

Validation of anaphylaxis in the Food and Drug Administration's Mini-Sentinel by Walsh, Kathleen E., Cutrona, Sarah L., Foy, Sarah, Baker, Meghan A., Forrow, Susan, Shoaibi, Azadeh, Pawloski, Pamala A., Conroy, Michelle, Fine, Andrew M., Nigrovic, Lise E., Selvam, Nandini, Selvan, Mano S., Cooper, William O., Andrade, Susan

“…ABSTRACT Purpose We aim to develop and validate the positive predictive value (PPV) of an algorithm to identify anaphylaxis using health plan administrative…”
Get full text

Universal Use of N95 Respirators in Healthcare Settings When Community Coronavirus Disease 2019 Rates Are High by Klompas, Michael, Rhee, Chanu, Baker, Meghan A

“…Abstract The Centers for Disease Control and Prevention recommends N95 respirators for all providers who see patients with possible or confirmed coronavirus…”
Get full text

Survey of coronavirus disease 2019 (COVID-19) infection control policies at leading US academic hospitals in the context of the initial pandemic surge of the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) omicron variant by Rhee, Chanu, Baker, Meghan A., Klompas, Michael

“…To assess coronavirus disease 2019 (COVID-19) infection policies at leading US medical centers in the context of the initial wave of the severe acute…”
Get full text

Coronavirus Disease 2019’s Challenges to Infection Control Dogma Regarding Respiratory Virus Transmission by Klompas, Michael, Baker, Meghan A, Rhee, Chanu

Get full text

Lack of Comprehensive Outbreak Detection in Hospitals by Baker, Meghan A., Huang, Susan S., Letourneau, Alyssa R., Kaganov, Rebecca E., Peeples, Jennifer R., Drees, Marci, Platt, Richard, Yokoe, Deborah S.

“…Timely identification of outbreaks of hospital-associated infections is needed to implement control measures and minimize impact. Survey results from 33…”
Get full text

Prevention of SARS-CoV-2 and respiratory viral infections in healthcare settings: current and emerging concepts by Rhee, Chanu, Baker, Meghan A., Klompas, Michael

“…COVID-19 has catalyzed a wealth of new data on the science of respiratory pathogen transmission and revealed opportunities to enhance infection prevention…”
Get full text

Strategic Masking to Protect Patients from All Respiratory Viral Infections by Klompas, Michael, Baker, Meghan A., Rhee, Chanu, Baden, Lindsey R.

“…With the end of the Covid-19 public health emergency, health care facilities could reimagine masking polices to protect patients from the full array of…”
Get full text

The COVID-19 infection control arms race by Rhee, Chanu, Baker, Meghan A, Klompas, Michael

“…US hospitals are engaged in an infection control arms race. Hospitals, specialties, and professional groups are spurring one another on to adopt progressively…”
Get full text

Sources of exposure identified through structured interviews of healthcare workers who test positive for severe acute respiratory coronavirus virus 2 (SARS-CoV-2): A prospective analysis at two teaching hospitals by Rhee, Chanu, Baker, Meghan A., Tucker, Robert, Griesbach, Diane, McDonald, Dinah, Williams, Sarah A., Fiumara, Karen, Resnick, Andrew, Klompas, Michael

“…Abstract We interviewed 1,208 healthcare workers with positive SARS-CoV-2 tests between October 2020 and June 2021 to determine likely exposure sources…”
Get full text

The Impact of Coronavirus Disease 2019 (COVID-19) on Healthcare-Associated Infections by Baker, Meghan A, Sands, Kenneth E, Huang, Susan S, Kleinman, Ken, Septimus, Edward J, Varma, Neha, Blanchard, Jackie, Poland, Russell E, Coady, Micaela H, Yokoe, Deborah S, Fraker, Sarah, Froman, Allison, Moody, Julia, Goldin, Laurel, Isaacs, Amanda, Kleja, Kacie, Korwek, Kimberly M, Stelling, John, Clark, Adam, Platt, Richard, Perlin, Jonathan B

“…Abstract Background The profound changes wrought by coronavirus disease 2019 (COVID-19) on routine hospital operations may have influenced performance on…”
Get full text

Impact of SARS-CoV-2 Prevention Measures on Non-SARS-CoV-2 Hospital-Onset Respiratory Viral Infections: An Incidence Trend Analysis From 2015-2023 by Ehrenzeller, Selina, Chen, Tom, Vaidya, Vineeta, Rhee, Chanu, Baker, Meghan A, Klompas, Michael

“…We reviewed hospital-onset respiratory viral infections, 2015-2023, in one hospital to determine whether Severe Acute Respiratory Syndrome Coronavirus 2…”
Get full text